These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active. Yarden Y. Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2569-73. PubMed ID: 1969636 [Abstract] [Full Text] [Related]
44. Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancer. McKenzie SJ, DeSombre KA, Bast BS, Hollis DR, Whitaker RS, Berchuck A, Boyer CM, Bast RC. Cancer; 1993 Jun 15; 71(12):3942-6. PubMed ID: 8099528 [Abstract] [Full Text] [Related]
45. Expression of Her2/neu oncogene product p185 in correlation to clinicopathological and prognostic factors of gastric carcinoma. Jaehne J, Urmacher C, Thaler HT, Friedlander-Klar H, Cordon-Cardo C, Meyer HJ. J Cancer Res Clin Oncol; 1992 Jun 15; 118(6):474-9. PubMed ID: 1352299 [Abstract] [Full Text] [Related]
47. Greater enhancement of chemosensitivity by caffeine in high-p185neu-expressing human non-small-cell lung cancer cell lines. Tsai CM, Perng RP, Chen MH, Jan YH, Hung MC, Ku TY, Chang KT. J Natl Cancer Inst; 1994 Jul 06; 86(13):1018-20. PubMed ID: 7911844 [No Abstract] [Full Text] [Related]
50. Association of p185neu with microfilaments via a large glycoprotein complex in mammary carcinoma microvilli. Evidence for a microfilament-associated signal transduction particle. Carraway CA, Carvajal ME, Li Y, Carraway KL. J Biol Chem; 1993 Mar 15; 268(8):5582-7. PubMed ID: 8095497 [Abstract] [Full Text] [Related]
51. Abnormalities of protooncogenes in non-small cell lung cancer. Correlations with tumor type and clinical characteristics. Cline MJ, Battifora H. Cancer; 1987 Dec 01; 60(11):2669-74. PubMed ID: 3677003 [Abstract] [Full Text] [Related]
52. Human neu oncogene is expressed in endometrial but not in ovarian adenocarcinomas. Garuti G, Genazzani AR. Cancer; 1991 Mar 15; 67(6):1713. PubMed ID: 1672104 [No Abstract] [Full Text] [Related]
57. Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model. Ahad A, K Saeed H, Del Solar V, López-Hernández JE, Michel A, Mathew J, Lewis JS, Contel M. ACS Pharmacol Transl Sci; 2023 Dec 08; 6(12):1972-1986. PubMed ID: 38093840 [Abstract] [Full Text] [Related]
58. Immunogenicity and antitumor efficacy of a novel human PD-1 B-cell vaccine (PD1-Vaxx) and combination immunotherapy with dual trastuzumab/pertuzumab-like HER-2 B-cell epitope vaccines (B-Vaxx) in a syngeneic mouse model. Kaumaya PTP, Guo L, Overholser J, Penichet ML, Bekaii-Saab T. Oncoimmunology; 2020 Oct 01; 9(1):1818437. PubMed ID: 33117602 [Abstract] [Full Text] [Related]
59. B-cell epitope peptide cancer vaccines: a new paradigm for combination immunotherapies with novel checkpoint peptide vaccine. Kaumaya PT. Future Oncol; 2020 Aug 01; 16(23):1767-1791. PubMed ID: 32564612 [Abstract] [Full Text] [Related]